raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79084

Familial partial lipodystrophy, Köbberling type

Synonyms: FPLD1 · Familial partial lipodystrophy type 1

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Childhood
Status
active

Familial partial lipodystrophy, Köbberling type, is a very rare form of familial partial lipodystrophy (FPLD) of unknown etiology characterized by lipoatrophy that is confined to the limbs and a normal or increased fat distribution of the face, neck, and trunk. Arterial hypertension and diabetes have also been associated. Inheritance is thought to be autosomal dominant.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFamilial partial lipodystrophy, Köbberling typeFPLD1 · Familial partial lipodystrophy type 1
frLipodystrophie partielle familiale type KöbberlingLDPF1 · Lipodystrophie partielle familiale type 1
deLipodystrophie, familiäre partielle, Typ Köbberling
esLipodistrofia parcial familiar tipo KöbberlingFPLD1 · Lipodistrofia familiar parcial tipo 1
itLipodistrofia parziale familiare, tipo KöbberlingFPLD1 · Lipodistrofia parziale familiare, tipo 1
nlFamiliale partiële lipodystrofie, Köbberling-typeFPLD1 · Familiale partiële lipodystrofie type 1
ptLipodistrofia parcial familiar, tipo KöbberlingFPLD1 · Lipodistrofia parcial familiar tipo 1
plRodzinna lipodystrofia częściowa, typ KöbberlingaFplD1 · Rodzinna lipodystrofia częściowa typu 1
csFamiliární parciální lipodystrofie, Köbberlingův typFPLD1 · Familiární parciální lipodystrofie, typ 1
ukСімейна часткова ліподистрофія, тип КебберлінгаСімейна часткова ліподистрофія типу 1 · FPLD1
zh家族性部分脂肪营养障碍,K÷bberling 型家族性部分性脂肪营养不良1型
trAilesel kısmi lipodistrofi, Köbberling tipiFPLD1 · Ailesel kısmi lipodistrofi tip 1

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM608600Evalidated
ICD-10E88.1NTBTattributedvalidated
ICD-115A44NTBTindexvalidated
MONDO0012072Evalidated
UMLSC1720859Evalidated
GARD12598Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
LMNACandidate gene tested inNot yet assessedHGNC:6636ENSG000001607891503301q22lamin A/C15298354[PMID]_18041775[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families20 casesWorldwideCase(s)Validated16409151[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

12 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000819Diabetes mellitus
HP:0000842Hyperinsulinemia
HP:0000822Hypertension
HP:0000855Insulin resistance
HP:0100578Lipoatrophy
Frequent (79-30%)
HP:0001397Hepatic steatosis
HP:0002240Hepatomegaly
HP:0000147Polycystic ovaries
HP:0000991Xanthomatosis
Occasional (29-5%)
HP:0000956Acanthosis nigricans
HP:0001677Coronaryartery atherosclerosis
HP:0001733Pancreatitis

Run the differential on the 5 obligate / very frequent terms

Annotation source: 12766116[PMID]

7

Sources for this card